OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2020
(3)
2021
(2)
2023
(1)
2015
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Not available
S-EPMC5569675
|
biostudies-literature
Cite
Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice.
Not available
S-EPMC4816239
|
biostudies-literature
Cite
Prediction of postoperative infection in elderly using deep learning-based analysis: an observational cohort study.
Not available
S-EPMC10014765
|
biostudies-literature
Cite
Repositioning of the global epicentre of non-optimal cholesterol.
Not available
S-EPMC7332422
|
biostudies-literature
Cite
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.
Not available
S-EPMC8446938
|
biostudies-literature
Cite
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.
Not available
S-EPMC7943191
|
biostudies-literature
Cite
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants.
Not available
S-EPMC7658740
|
biostudies-literature
Cite
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.
Not available
S-EPMC7272903
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets